InMode Reports Q1 2025 Results Amid Share Repurchase Completion

InMode ( (INMD) ) has shared an update.

InMode Ltd. announced its financial results for the first quarter of 2025, reporting a 3% year-over-year decrease in revenue to $77.9 million. Despite a challenging macroeconomic environment and weakened consumer demand, the company completed a significant share repurchase program, buying back 6.95 million shares for $127 million. InMode’s international performance, particularly in Europe, showed resilience with record revenue, while the U.S. market faced headwinds. The company remains focused on innovation and disciplined capital allocation, with a strong balance sheet supporting its strategic initiatives.

Spark’s Take on INMD Stock

According to Spark, TipRanks’ AI Analyst, INMD is a Outperform.

InMode scores well on financial performance due to strong profit margins and low leverage, indicating financial stability. However, technical analysis signals bearish momentum, posing a short-term risk. The low P/E ratio suggests potential undervaluation, yet earnings call data highlights revenue and margin challenges. Overall, while the company has a solid financial foundation, market challenges and bearish technical indicators temper the stock’s attractiveness.

To see Spark’s full report on INMD stock, click here.

More about InMode

InMode Ltd. is a leading global provider of innovative medical technologies, focusing on aesthetic treatments. The company is known for its advanced devices that cater to the medical aesthetics market, with a strong emphasis on technological innovation and operational excellence.

YTD Price Performance: -4.36%

Average Trading Volume: 1,313,449

Technical Sentiment Signal: Strong Buy

Current Market Cap: $1.13B

See more insights into INMD stock on TipRanks’ Stock Analysis page.